Centre for Immune Regulation, Department of Immunology, Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, Norway.
K.G. Jebsen Coeliac Disease Research Centre, Department of Immunology, and.
J Clin Invest. 2018 Jun 1;128(6):2642-2650. doi: 10.1172/JCI98819. Epub 2018 May 14.
Little is known about the repertoire dynamics and persistence of pathogenic T cells in HLA-associated disorders. In celiac disease, a disorder with a strong association with certain HLA-DQ allotypes, presumed pathogenic T cells can be visualized and isolated with HLA-DQ:gluten tetramers, thereby enabling further characterization. Single and bulk populations of HLA-DQ:gluten tetramer-sorted CD4+ T cells were analyzed by high-throughput DNA sequencing of rearranged TCR-α and -β genes. Blood and gut biopsy samples from 21 celiac disease patients, taken at various stages of disease and in intervals of weeks to decades apart, were examined. Persistence of the same clonotypes was seen in both compartments over decades, with up to 53% overlap between samples obtained 16 to 28 years apart. Further, we observed that the recall response following oral gluten challenge was dominated by preexisting CD4+ T cell clonotypes. Public features were frequent among gluten-specific T cells, as 10% of TCR-α, TCR-β, or paired TCR-αβ amino acid sequences of total 1813 TCRs generated from 17 patients were observed in 2 or more patients. In established celiac disease, the T cell clonotypes that recognize gluten are persistent for decades, making up fixed repertoires that prevalently exhibit public features. These T cells represent an attractive therapeutic target.
关于与 HLA 相关疾病中致病性 T 细胞的库动态和持久性知之甚少。在乳糜泻(一种与某些 HLA-DQ 同种异型强烈相关的疾病)中,假定的致病性 T 细胞可以用 HLA-DQ: 谷蛋白四聚体可视化和分离,从而能够进一步进行表征。通过对重排的 TCR-α 和 -β 基因进行高通量 DNA 测序,分析了 HLA-DQ: 谷蛋白四聚体分选的 CD4+T 细胞的单个和批量群体。从 21 名乳糜泻患者的血液和肠道活检样本中,在疾病的不同阶段以及相隔数周至数十年的时间间隔内进行了检查。在几十年中,在两个隔室中都观察到了相同克隆型的持久性,相隔 16 至 28 年的样本之间有高达 53%的重叠。此外,我们观察到,口服谷蛋白挑战后的回忆反应主要由预先存在的 CD4+T 细胞克隆型主导。在乳糜泻患者中,公共特征在谷蛋白特异性 T 细胞中很常见,因为从 17 名患者中生成的总共 1813 个 TCR 中,有 10%的 TCR-α、TCR-β 或配对 TCR-αβ 氨基酸序列在 2 个或更多患者中被观察到。在已确诊的乳糜泻中,识别谷蛋白的 T 细胞克隆型持续存在数十年,构成了固定的库,主要表现出公共特征。这些 T 细胞代表了一个有吸引力的治疗靶点。